Surcolombiana De Neurociencias S.A.S. Company Profile - Colombia | Financials & Key Executives

Surcolombiana De Neurociencias S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Ambulatory Health Care Services

Full name: Surcolombiana De Neurociencias S.A.S.

Profile Updated: March 15, 2024

Surcolombiana De Neurociencias S.A.S. is an enterprise located in Colombia, with the main office in Neiva. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on September 13, 2011. From the latest financial highlights, Surcolombiana De Neurociencias S.A.S. reported a net sales revenue drop of 11.18% in 2023. Its’ total assets recorded a growth of 0.97%.

Headquarters
Carrera 9 No 11 - 13 Centro Medico Y Emp
Neiva; Huila;

Contact Details: Purchase the Surcolombiana De Neurociencias S.A.S. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Surcolombiana De Neurociencias S.A.S. report to view the information.

Incorporation Date:

September 13, 2011

Key Executives

Purchase this report to view the information.

Legal Representative

Company Performance

Financial values in the chart are available after Surcolombiana De Neurociencias S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.

Net sales revenue

-11.18%▼

Total operating revenue

-11.18%▼

Operating profit (EBIT)

39.79%▲

Net Profit (Loss) for the Period

N/A

Total assets

0.97%▲

Total equity

-4.6%▼

Operating Profit Margin (ROS)

10.33%▲

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt to Equity Ratio

-1.72%▼

Quick Ratio

-1.19%▼

Cash Ratio

-0.87%▼

Similar companies

Related EMIS Industry Reports